Katherine Dell, MD
Primary Location
Cleveland Clinic Main Campus
- Appointment:
- 216.444.5437
- Desk:
- 216.444.6123
- Fax:
- 216.448.6015
Additional Locations
Center for Pediatric Nephrology and Hypertension
Hillcrest Medical Building 2
6801 Mayfield Road
Mayfield Heights, OH 44124
Directions
- Appointment:
- 216.444.5437
- Desk:
- 216.444.6123
- Fax:
- 216.448.6015
Center for Pediatric Research
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, OH 44195
Directions
- Appointment:
- 216.444.5437
- Desk:
- 216.444.6123
- Fax:
- 216.448.6015
Specialty in Diseases & Conditions
- Blood in the Urine
- Chronic Kidney Disease
- Fetal Kidney Disease
- Focal Segmental Glomerulosclerosis (FSGS)
- High Creatinine Levels
- Inherited Kidney Disease
- Lupus Nephritis
- Metabolic Acidosis
- Nephrotic Syndrome
- Pediatric Kidney Birth Defects
- Polycystic Kidney Disease
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Katherine Dell, MD
Katherine M. Dell, M.D. is a board-certified Pediatric nephrologist and Director of Clinical and Translational Research for the Children's Institute. She sees patients at Cleveland Clinic Children's outpatient facility on Main campus as well as the Hillcrest Hospital medical office building
She received her medical degree from Harvard Medical School and completed pediatric residency and pediatric nephrology fellowship at Children's Hospital of Philadelphia.
She is a member of several professional organizations including the American Society of Pediatric Nephrology (ASPN), American Academy of Pediatrics (AAP and the Society for Pediatric Research (SPR) and the American Pediatric Society (APS).
Her research and clinical interests are in the areas of polycystic kidney disease (PKD) and other cystic kidney diseases (including tuberous sclerosis), obstructive uropathies (including posterior urethral valves), nephrotic syndrome and pediatric chronic kidney disease (CKD). She has published over 70 articles in peer-reviewed journals. She is the co-Principal Investigator for the IMAGE-ARPKD study, an NIH- funded prospective, observational study of novel MRI techniques to identify markers of ARPKD kidney disease progression. She is the site PI for the ongoing clinical trials of tolvaptan therapy for ARPKD. She is also the site Principal Investigator for several other clinical research studies and networks including Chronic Kidney Disease in Children (CKID), Nephrotic Syndrome Study Network (NEPTUNE), the FIONA trial and North American Pediatric Renal Trials Cooperative Study (NAPRTCs).
Education & Professional Highlights
Appointed
2013
Education & Fellowships
Fellowship - Children's Hospital of Philadelphia
Pediatric Nephrology
Philadelphia,
PA
1998
Residency - Children's Hospital of Philadelphia
Pediatrics
Philadelphia,
PA
1995
Medical Education - Harvard University Medical School
Boston,
MA
1992
Undergraduate - Yale University
New Haven,
CT
1987
Certifications
- Pediatrics - Pediatric Nephrology
- Pediatrics
Specialty Interests
Inherited kidney diseases, polycystic kidney disease, congenital kidney malformations
Research & Publications
See publications for Katherine Dell, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/29/2024, Dr. Dell has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.